Cargando…
Evaluation of Everolimus Activity against Mycobacterium tuberculosis Using In Vitro Models of Infection
Even though Everolimus has been investigated in a phase II randomized trial as a host-directed therapy (HDT) to treat tuberculosis (TB), an oncological patient treated with Everolimus for a neuroendocrine pancreatic neoplasia developed active TB twice and a non-tuberculous mycobacterial (NTM) infect...
Autores principales: | Bianco, Delia Mercedes, De Maio, Flavio, Santarelli, Giulia, Palucci, Ivana, Salustri, Alessandro, Bianchetti, Giada, Maulucci, Giuseppe, Citterio, Franco, Sanguinetti, Maurizio, Tamburrini, Enrica, Sali, Michela, Delogu, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854797/ https://www.ncbi.nlm.nih.gov/pubmed/36671372 http://dx.doi.org/10.3390/antibiotics12010171 |
Ejemplares similares
-
Evaluation of the Toxic Activity of the Graphene Oxide in the Ex Vivo Model of Human PBMC Infection with Mycobacterium tuberculosis
por: Salustri, Alessandro, et al.
Publicado: (2023) -
Inhibition of Transglutaminase 2 as a Potential Host-Directed Therapy Against Mycobacterium tuberculosis
por: Palucci, Ivana, et al.
Publicado: (2020) -
Cysteamine/Cystamine Exert Anti-Mycobacterium abscessus Activity Alone or in Combination with Amikacin
por: Palucci, Ivana, et al.
Publicado: (2023) -
Graphene Oxide-Linezolid Combination as Potential New Anti-Tuberculosis Treatment
por: De Maio, Flavio, et al.
Publicado: (2020) -
PE_PGRS3 ensures provision of the vital phospholipids cardiolipin and phosphatidylinositols by promoting the interaction between M. tuberculosis and host cells
por: De Maio, Flavio, et al.
Publicado: (2021)